CN Patent

CN116568302B — 杂环取代的稠合γ-咔啉类衍生物、其制备方法、中间体及应用

Assigned to Shanghai Shujing Biotechnology Co ltd · Expires 2025-04-18 · 1y expired

What this patent protects

涉及一种杂环取代的稠合γ‑咔啉类衍生物、及其制备方法、中间体及其应用，其具有如式(I)所示化合物结构，该类化合物可用于制备治疗神经精神疾病的药物。

USPTO Abstract

涉及一种杂环取代的稠合γ‑咔啉类衍生物、及其制备方法、中间体及其应用，其具有如式(I)所示化合物结构，该类化合物可用于制备治疗神经精神疾病的药物。

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: CN116568302B
Jurisdiction: CN
Classification: —
Expires: 2025-04-18
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Shujing Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.